Skip to Main Content

Paper Details

Modulation of Bax and mTOR for Cancer Therapeutics.
Cancer Res
22
2017
Bax, Bax homooligomers, C, CYD, CYD-2-11, Cancer, RAD001, S184, S184 Bax, SMBA1, anticancer, lung cancer, lung cancer cells, mTOR, mutant KRAS, mutant KRAS-driven lung cancer, normal tissues, patient, patients, proapoptotic Bcl2 family member Bax, serine, small-cell and non-small cell lung cancers
Author NameAffiliation
Guo ChenEmory University School of Medicine and Winship Cancer Institute of Emory University
Guo ChenEmory University School of Medicine and Winship Cancer Institute of Emory University
Andrew T MagisInstitute for Systems Biology
  • 1 - 3

Datasets

Release 1.2